Evolve Private Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
2,999
-241
-7% -$16.1K 0.01% 944
2026
Q1
$203K Sell
3,240
-1,032
-24% -$71.9K 0.01% 930
2025
Q4
$284K Buy
+4,272
New +$276K 0.02% 752

Other funds holding DXCM

Evolve Private Wealth's DXCM Position: Q2 2026 in Review

Evolve Private Wealth reduced its DexCom (DXCM) stake by 7.4% in Q2 2026, selling an estimated $16.1K and leaving 2,999 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #944.

Evolve Private Wealth first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. The position peaked at $284K in Q4 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Evolve Private Wealth held 2,999 shares of DexCom worth $202K as of Q2 2026.
  • Evolve Private Wealth sold 241 DexCom shares in Q2 2026, an estimated $16.1K.
  • DexCom made up 0.01% of Evolve Private Wealth's portfolio in Q2 2026, its #944 holding.
  • Evolve Private Wealth first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's DexCom position peaked at $284K in Q4 2025.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.